The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
Format:Paperback
Language:English
ISBN:0309148839
ISBN13:9780309148832
Release Date:January 2011
Publisher:National Academies Press
Length:88 Pages
Recommended
Format: Paperback
Condition: New
$25.11
Backordered
If the item is not restocked at the end of 90 days, we will cancel your backorder and issue you a refund.
ThriftBooks sells millions of used books at the lowest everyday prices. We personally assess every book's quality and offer rare, out-of-print treasures. We deliver the joy of reading in recyclable packaging with free standard shipping on US orders over $15. ThriftBooks.com. Read more. Spend less.